GRCL - Gracell Biotechnologies to Participate in Three Upcoming Investor Conferences | Benzinga
SAN DIEGO and SUZHOU, China and SHANGHAI, China, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (NASDAQ:GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to discovering and developing innovative and highly efficacious cell therapies for the treatment of cancer, today announced that the management team will participate in and attend one-on-one meetings at three upcoming investor conferences.
Stifel 2023 Immunology and Inflammation Virtual Summit
Fireside Chat: Wednesday, September 20th at 10:15 am ET
Presenter: Dr. Kevin Xie, Chief Financial Officer
Location: Virtual
Jefferies Cell & Genetic Medicine Summit
Fireside Chat: Tuesday, September 26th at ...